← All trials
NCT05236608
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 12, 2021
- Primary completion
- May 31, 2024
- Completion date
- May 31, 2024
- First posted
- Feb 11, 2022
- Last posted
- Mar 25, 2022
- Enrollment
- 53
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National University of SingaporeLead sponsor
- Adagene IncCollaborator
- National University of SingaporeOverall official - principal investigator
- Singapore Translational Cancer ConsortiumCollaborator
- Bristol-Myers SquibbCollaborator
- National University of SingaporeOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.